MME and neoplasm: Previously, we identified a subset of CD10+GPR77+ CAFs that promote tumor formation and chemoresistance by providing a survival niche for CSCs.[25] The induction of CD10+GPR77+ CAFs is triggered by complement signaling via GPR77.